iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析

◆英語タイトル:iCAD Inc (ICAD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013825
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
iCAD Inc (iCAD) is a medical device company. It develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD products find application in detection and treatment of breast, prostate and colorectal cancers. The company markets products through direct sales organization, OEM partners, distributors and resellers. The company has manufacturing facility in New Hampshire and an operation, manufacturing, warehouse, research and development facility in San Jose, California. The company operates primarily in the US and it also exports products to various countries in Europe and Asia. iCAD is headquartered in Nashua, New Hampshire, the US.

iCAD Inc (ICAD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
iCAD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
iCAD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
iCAD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
iCAD Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
iCAD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
iCAD Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
iCAD Acquires Rights to M-Vu CAD from VuCOMP 11
Partnerships 12
Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions 12
iCAD Enters Into Distribution Agreement With Carestream Health 13
iCAD Enters Into Distribution Agreement With Hitachi Medical Systems 14
iCAD Enters Into Partnership Agreement With Matakina 15
Equity Offering 16
iCad Completes Public Offering Of Shares For US$30.4 Million 16
Asset Transactions 18
Invivo Acquires Assets of iCAD 18
Acquisition 19
iCAD Acquires DermEbx and Radion for USD13 Million 19
iCAD Inc – Key Competitors 20
iCAD Inc – Key Employees 21
iCAD Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 08, 2017: iCAD Reports Third Quarter 2017 Financial Results 23
Aug 08, 2017: iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank 25
May 02, 2017: iCAD Reports First-quarter 2017 Financial Results 27
Mar 08, 2017: iCAD Reports Fourth Quarter and Full Year 2016 Financial Results 29
Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results 31
Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results 33
May 03, 2016: ICAD Reports First Quarter 2016 Financial Results 35
Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results 37
Corporate Communications 39
Sep 08, 2016: iCAD Announces Management Transition 39
Product News 40
Nov 28, 2016: iCAD to Showcase Use of Artificial Intelligence in Medical Imaging at RSNA 2016 40
03/04/2016: iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016 41
Other Significant Developments 42
Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
iCAD Inc, Medical Equipment, Key Facts, 2016 2
iCAD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
iCAD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
iCAD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
iCAD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
iCAD Inc, Deals By Market, 2011 to YTD 2017 9
iCAD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
iCAD Acquires Rights to M-Vu CAD from VuCOMP 11
Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions 12
iCAD Enters Into Distribution Agreement With Carestream Health 13
iCAD Enters Into Distribution Agreement With Hitachi Medical Systems 14
iCAD Enters Into Partnership Agreement With Matakina 15
iCad Completes Public Offering Of Shares For US$30.4 Million 16
Invivo Acquires Assets of iCAD 18
iCAD Acquires DermEbx and Radion for USD13 Million 19
iCAD Inc, Key Competitors 20
iCAD Inc, Key Employees 21
iCAD Inc, Other Locations 22
iCAD Inc, Subsidiaries 22

★海外企業調査レポート[iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MOL Group:企業の戦略・SWOT・財務情報
    MOL Group - Strategy, SWOT and Corporate Finance Report Summary MOL Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Innophos Holdings Inc (IPHS):企業の財務・戦略的SWOT分析
    Innophos Holdings Inc (IPHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Toyota Tsusho Corporation:戦略・SWOT・企業財務分析
    Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report Summary Toyota Tsusho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CITGO Petroleum Corp:企業の戦略的SWOT分析
    CITGO Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Aker ASA (AKER)-石油・ガス分野:企業M&A・提携分析
    Summary Aker ASA (Aker) is an industrial investment company, which operates through in two areas, Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor A …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Belfius Bank Sa
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Neogen Corp (NEOG):企業の財務・戦略的SWOT分析
    Neogen Corp (NEOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • U.S. HealthWorks Medical Group:企業のM&A・事業提携・投資動向
    U.S. HealthWorks Medical Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. HealthWorks Medical Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Power Climber Wind:企業の戦略的SWOT分析
    Power Climber Wind - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Agthia Group PJSC:企業の戦略・SWOT・財務情報
    Agthia Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Agthia Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Reliable Ventures India Limited:戦略・SWOT・企業財務分析
    Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report Summary Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析
    Summary Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutic …
  • Enmax Corp:企業の戦略的SWOT分析
    Enmax Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sierra Oncology Inc (SRRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kulim (Malaysia) Bhd:企業の戦略的SWOT分析
    Kulim (Malaysia) Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • PSR Group BV:製薬・医療:M&Aディール及び事業提携情報
    Summary PSR Group BV (PSR) is a contract research and staffing consultancy service provider. The company operates through two divisions such as PSR Orphan Experts and PSR Pharma Resource. Its PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. The com …
  • Mitsubishi Gas Chemical Co Inc (4182):企業の財務・戦略的SWOT分析
    Mitsubishi Gas Chemical Co Inc (4182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆